These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9141527)
1. Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity. Ciaraldi TP; Morales AJ; Hickman MG; Odom-Ford R; Olefsky JM; Yen SS J Clin Endocrinol Metab; 1997 May; 82(5):1421-5. PubMed ID: 9141527 [TBL] [Abstract][Full Text] [Related]
2. Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome. Ciaraldi TP; Morales AJ; Hickman MG; Odom-Ford R; Yen SS; Olefsky JM Metabolism; 1998 Aug; 47(8):940-6. PubMed ID: 9711989 [TBL] [Abstract][Full Text] [Related]
3. Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. Ciaraldi TP J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1291-3. PubMed ID: 11117672 [TBL] [Abstract][Full Text] [Related]
4. Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance? Ek I; Arner P; Bergqvist A; Carlström K; Wahrenberg H J Clin Endocrinol Metab; 1997 Apr; 82(4):1147-53. PubMed ID: 9100587 [TBL] [Abstract][Full Text] [Related]
5. Adipocyte insulin action following ovulation in polycystic ovarian syndrome. Marsden PJ; Murdoch AP; Taylor R Hum Reprod; 1999 Sep; 14(9):2216-22. PubMed ID: 10469683 [TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. Ciaraldi TP; Aroda V; Mudaliar S; Chang RJ; Henry RR J Clin Endocrinol Metab; 2009 Jan; 94(1):157-63. PubMed ID: 18854391 [TBL] [Abstract][Full Text] [Related]
7. Severe impairment of insulin action in adipocytes from amenorrheic subjects with polycystic ovary syndrome. Marsden PJ; Murdoch A; Taylor R Metabolism; 1994 Dec; 43(12):1536-42. PubMed ID: 7990708 [TBL] [Abstract][Full Text] [Related]
8. Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness. Lystedt E; Westergren H; Brynhildsen J; Lindh-Astrand L; Gustavsson J; Nystrom FH; Hammar M; Strålfors P Eur J Endocrinol; 2005 Dec; 153(6):831-5. PubMed ID: 16322388 [TBL] [Abstract][Full Text] [Related]
9. Tissue insulin sensitivity and body weight in polycystic ovary syndrome. Marsden PJ; Murdoch AP; Taylor R Clin Endocrinol (Oxf); 2001 Aug; 55(2):191-9. PubMed ID: 11531925 [TBL] [Abstract][Full Text] [Related]
10. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels. Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364 [TBL] [Abstract][Full Text] [Related]
11. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS). Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507 [TBL] [Abstract][Full Text] [Related]
12. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet. Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398 [TBL] [Abstract][Full Text] [Related]
13. Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome. Wahrenberg H; Ek I; Reynisdottir S; Carlström K; Bergqvist A; Arner P J Clin Endocrinol Metab; 1999 Jun; 84(6):2182-7. PubMed ID: 10372729 [TBL] [Abstract][Full Text] [Related]
14. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. Ciaraldi TP; el-Roeiy A; Madar Z; Reichart D; Olefsky JM; Yen SS J Clin Endocrinol Metab; 1992 Aug; 75(2):577-83. PubMed ID: 1322430 [TBL] [Abstract][Full Text] [Related]
15. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842 [TBL] [Abstract][Full Text] [Related]
16. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance. Højlund K Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125 [TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome. Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552 [TBL] [Abstract][Full Text] [Related]
18. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369 [TBL] [Abstract][Full Text] [Related]
19. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance. Sepilian V; Nagamani M J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109 [TBL] [Abstract][Full Text] [Related]
20. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Ek I; Arner P; Rydén M; Holm C; Thörne A; Hoffstedt J; Wahrenberg H Diabetes; 2002 Feb; 51(2):484-92. PubMed ID: 11812759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]